Skip to main content
Equibles
GOCOQ logo

GOCOQ · GoHealth, Inc.

Track GOCOQ — free

Use GOCOQ with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.34 +0.03 (+8.71%) At close · Jul 21
Rebalance outlook locked
Going-concern doubt — flagged May 18, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Because of the uncertainty of (i) successfully completing operational initiatives to comply with the minimum liquidity covenant and (ii) the outcome of the discussions with the Company's lenders and other stakeholders, management has concluded there is substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that these Condensed Consolidated Financial Statements are issued.”
View the 10-Q filed May 18, 2026
Market Cap
$9.87M
Shares
29.30M

GOCOQ metrics

43 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.34
Market cap
$9.87M

Price action

19 metrics
Price change (1W)
—
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Financial Services
Industry
Insurance Brokers
Shares outstanding
29.30M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.1×
reciprocal yield 24.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 1,547.2%
P / book
4.6
reciprocal yield 21.6%
FCF yield
-1,091.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2,935.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-11-13

Profitability

9 metrics
Gross margin
57.3%
Operating margin
-297.4%
Trailing 12 months
Net margin
-189.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$454.36M
Net income (TTM)
−$289.89M
Trailing 12 months
Diluted EPS (TTM)
$-22.01
FCF margin
-70.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.02

Growth

11 metrics
Revenue growth YoY
-94.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$152.79M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+56.1%
Year over year · more shares
Revenue CAGR (3Y)
-16.9%
Revenue CAGR (5Y)
-16.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-13,603.4%
Return on assets
-31.6%
Debt / equity
306.5
Current ratio
2.0
EBITDA (TTM)
−$447.46M
Free cash flow (TTM)
−$107.76M
Quick ratio
2.0
Interest coverage
-4.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$613.25M
Latest balance sheet
Cash & equivalents
$39.88M
Total assets
$917.92M
Total debt
$653.13M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$102.56M
Capital expenditures (TTM)
$5.20M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$8.94M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
5
13F filer change QoQ
-62
Institutional ownership
0.3%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1808220 CUSIP 38046W204 13F (30d) 2 filings 2 filers Visit website Investor relations